In light of litifilimab recently receiving FDA Breakthrough Therapy Designation for CLE, we spoke with experts to discuss diagnostic and treatment gaps in disease management.

Late-breaking AMETHYST Part A study results to be presented, showing safety and efficacy of litifilimab in cutaneous lupus erythematosus ...

Medications to manage your lupus can be overwhelming, but it’s important to remember that your local pharmacist can help. In this episode of The Expert Series, we speak with Dr. Marcia Mueting, CEO of ...

For decades, treatments for lupus, which affects 1.5 million Americans, have been few and far between. The condition affects mainly women and can be debilitating. Now, a promising clinical trial ...

Nipocalimab has been granted U.S. Food and Drug Administration Fast Track designation as a potential treatment for adults with systemic lupus erythematosus (SLE). Fast Track designation is designed to ...

Please provide your email address to receive an email when new articles are posted on . Current treatment paradigms for lupus nephritis offer significant room for improvement, according to a presenter ...

Brickell Rheumatology Wellness Center, based in Miami, Florida, announced an educational initiative focused on raising awareness about lupus medication side effects. The clinic aims to help patients ...

A 19-year-old Chinese woman with a history of systemic lupus erythematous (SLE) visits a rheumatology clinic. She is 24-weeks pregnant and reports ...

Lupus is more common in Black people, and symptoms can be different too. Here's what to look out for and how to treat it.